Lanternedx

Drug Discovery · Clinical Trial Services (CRO)

Overview

Customized histopathology services to support biomarker discovery and validation. Fast, reliable solutions for research. Get a quote today.

Funding and backers

Backers
1
Ampersand Capital Partners
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 2026 Formerly Lanterne Dx (flagshipbio.com) 2019 Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Meadowhawk BiolabsVenture round $5M · 2 yr ago · Founded 2021 · 1 role
Leading contract research organization for preclinical CRO services and clinical trials. Advancing drug discovery with expert research…
AnaBiosVenture round $6.5M · 4 yr ago
AnaBios provides high quality human tissue and cells, including heart, lung and dorsal root ganglia, for drug discovery & academic research.
Resolian is a specialist bioanalytical, biomarker and analytical sciences CRO supporting drug development with labs in USA, UK, Australia…
Discover P95 full-service CRO clinical trial solutions. Experts in epidemiology and real-world evidence for vaccines and infectious…
Regor combines a cutting-edge drug discovery engine with target validation and optimization for preclinical candidates in metabolism…
Advanced 3D and multi-tissue biology for predictive drug discovery. Ready-to-use microtissues for efficacy, safety, DMPK-Tox & biomarker…

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
64 portfolio companies: NATCA, VIVEbiotech, Akeura and 61 more